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The purpose of this study is to look at the prevalence of laryngopharyngeal reﬂux disease in patients with goiter in a group of 52
patients with goiter. All participants were asked to respond to the 9 questions on the Reﬂux Symptom Index (RSI). A diagnosis of
LPRD based on symptoms was made for any RSI score above 10. The average score of every question was computed for all patients
with goiter and compared to the corresponding average score of the controls. A P value of less than 0.05 was considered statistically
signiﬁcant.ThetotalprevalenceofLPRDinpatientswithgoiterasindicatedbyanRSIscoregreaterthan10was15.4%versus9.1%
in controls. The diﬀerence was not statistically signiﬁcant (P value 0.525). Looking at the average score of the individual symptoms
aslistedintheRSIquestionnaire,theaveragescoreofallthesymptomswashigherinpatientswithgoiterversuscontrols.Therewas
no correlation between LPRD and any of the demographic variables except for nodules (P value 0.035). The presence of laryn-
gopharyngeal symptoms in patients with goiter should alert the treating physician to the presence of laryngopharyngeal reﬂux
disease.
1.Introduction
Goiter is the most prevalent endocrine condition in the
world, aﬀecting over 500 million people [1]. Large cross-sec-
tional studies have demonstrated prevalence rates of goiters
and/or thyroid nodules between 25 and 33% [2, 3]. In other
studies, 26–30% of children [4] have been found to have a
goiter long after iodization of salt was standardized in those
settings.
Goiters occur as a result of the interplay of genetics and
environmental factors, namely, iodine deﬁciency [5]. The
importantroleofadequateiodineintakeanduptakehaslong
beenestablished.Deﬁcientlevelsleadtohypothyroidismthat
in turn leads to increased blood levels of TSH, which has a
hypertrophic eﬀect on the thyroid [5]. Certain conditions,
such as smoking or increased parity, may worsen iodine deﬁ-
ciency and can thus be considered risk factors for goiter [6].
In addition, genetic predisposition plays a crucial role in goi-
terogenesis [7]. In a region with low iodine support, patients
with goiters were found to have signiﬁcantly higher propor-
tion of parents (P<0.001; OR = 3.6) or siblings (P = 0.004;
OR = 2.5) with goiters, and patients with a positive goiter
family history had a 4.1-fold increased goiter risk. Similarly
children of parents with goiters showed a 2.7-fold increased
r i s kf o rg o i t e rd e v e l o p m e n t .
Goiter patients typically present with one or more of a
constellation of symptoms that include compressive symp-
toms such as globus pharyngeus and dysphagia, phonatory
symptoms such as hoarseness, cosmetic complaints as an en-
larged or palpable neck mass, or airway diﬃculty due to
tracheal compression, shift, or invasion [1]. Many of these
symptoms also occur in laryngopharygneal reﬂux disease
(LPRD), which is deﬁned broadly as the backﬂow of gastric
contentsintothelaryngopharynx.Thiscommonconditionis
found in roughly 50% of patients with a throat-related com-
plaint [8]. The most common symptoms include hoarseness,
globus, dysphagia, throat clearing, and cough, whereas the
most laryngeal ﬁndings are edema, erythema, thick mucus,
and muscle tension patterns [9].
Fiorentinoetal.[10]examinedthisveryoverlapofsymp-
toms by conducting a study on 25 goiter patients who
complained of local neck symptoms (throat discomfort,2 ISRN Endocrinology
dysphagia, hoarseness). They found that reﬂux laryngophar-
yngitiswaspresentin58–67%ofparticipants,basedonvideo
laryngoscopy, and that swallowing alterations, as demon-
strated on videoﬂuoroscopic swallowing study, were present
in86–90%[10].Interestingly,allparticipantsthenhadatotal
thyroidectomy as treatment of the goiter; yet, 75% or more
continued experiencing the local neck symptoms that had
presumably been due to their goiter. The authors concluded
these symptoms were likely due to the LPRD, which must
also then be addressed in order to relieve patients of the
symptoms that originally led them to present.
No other studies, to our knowledge, have examined the
interplay between LPRD and the presence of goiters. Even
Fiorentino et al. [10] only approach this question for goiter
patients already complaining of local neck symptoms; thus,
the select group they study is a biased sample of the overall
population of goitrous patients. Thus, the prevalence of
LPRD symptoms and ﬁndings in all goiter patients (regard-
less of original complaint) has yet to be investigated. This
study is a cross-sectional analysis of the prevalence of reﬂux
symptoms in consecutive patients seen at an endocrinology
oﬃce for management of goiter. It will also test whether or
not there is an association between the two conditions, that
is, whether or not patients with goiter have a higher prev-
alence of LPRD than those without goiter. Improved under-
standing of LPRD’s presence in this patient population will
help direct optimal treatment for symptoms that may other-
wise be attributed entirely to the presence of a goiter [10].
2. Methods
Participants were recruited over a period of two months at
a private endocrinology clinic at the American University of
Beirut Medical Center. All goiter patients (diagnosed clini-
cally and by ultrasound) between the ages of 18 and 65 were
informed of a study taking place in the adjacent Hamdan
Voice Unit regarding throat and vocal health and their pos-
sible association with goiter. A total of 52 consecutive pa-
tients with goiter were recruited for the study. Thirty-three
controls matched according to allergy and smoking status
were recruited as well. The authors made sure to have the
same percentages of smokers and subjects with allergy in
both patients and controls in order to address the confound-
ing eﬀect of smoking and allergy in the assessment of laryn-
gopharyngeal symptom. Patients with current upper respira-
tory infection symptoms or history of laryngeal manipula-
tion were excluded.
Demographicdataincludedage,gender,smoking,allergy
using a validated questionnaire [11, 12] duration of disease
in years, presence of one or more nodules as documented
by ultrasound, and thyroid stimulating hormonal level. A
range between 0.27 and 4.20micro-unit/mL was considered
as normal.
All participants were asked to respond to the 9 questions
ontheReﬂuxSymptomIndex(RSI)[13],andtheirresponses
were recorded on the scale by one of two research assistants
following an assigned protocol. A diagnosis of LPRD based
on symptoms was made for any RSI score above 10. The
prevalence of LPRD in patients with hypothyroidism was
compared to controls. In addition to the recording of the
total score of RSI in all subjects and the frequency of scores
above 10 as being indicative of LPRD, the average score of
every question was computed for all patients with goiter and
compared to the corresponding average score of the controls.
A P value of less than 0.05 was considered as statistically
signiﬁcant.
Frequenciesandmeans(±standarddeviation)wereused
todescribecategoricalandcontinuousvariables,respectively.
At the bivariate level, normal distribution was not assumed
for the total reﬂux symptoms in Table 3 and Wilcoxon-Mann
and Whitney Rank Sum Test was used to determine any
signiﬁcant diﬀerences in means of each continuous variable
when compared between patients and controls and for the
duration of disease with RSI. As for the age, the independent
t-test w a su s e df o ra g ei nTable 4. Pearson’s chi-square test was
applied for categorical variables in Tables 2 and 4 to assess
existence of any correlation. When expected count cells were
less than 5, Fisher’s exacttest was applied instead of Pearson’s
chi square. All analyses were conducted using the Statistical
Package for the Social Sciences version 17 software package.
A two-tailed P value of less than 0.05 was considered statis-
tically signiﬁcant.
3. Results
3.1. Demographic Data. A total of 52 patients with goiter
wererecruitedforthis study.The meanagewas47.37years ±
12.22 years. Eighty-eight per cent were females and almost
one-third was smoker. Eleven per cent had history of allergy.
The percentage for smoking and allergy was comparable in
controls. The mean duration of the disease since diagnosis
in patients was 3.32 years ± 4.17. Eight per cent had thyroid
gland nodules. With respect to their TSH level, 6 were miss-
ing and among those available, 70% were euthyroid at the
time of examination. See Table 1.
3.2. Prevalence of LPRD and Average Score of LPRD Symptoms
in Patients with Goiter and Controls. The total prevalence of
LPRD in patients with goiter as indicated by an RSI score
greater than 10 was 15.4% versus 9.1% in controls. The
diﬀerence was not statistically signiﬁcant (P value 0.525). See
Table 2.
Looking at the average score of the individual symptoms
as listed in the RSI questionnaire, the average score of all the
symptoms was higher in patients with goiter versus controls
but not signiﬁcantly higher. See Table 3.
3.3. Correlation between LPRD and Goiter Variables. There
was no correlation between LPRD and any of the demo-
graphic variables except for nodules. Goiter patients with
nodules were more likely to have LPRD compared to those
with no nodules. See Table 4.
4. Discussion
Laryngopharyngeal reﬂux is among the most common diag-
noses made in the laryngologist’s oﬃce, as roughly 50% ofISRN Endocrinology 3
Table 1: Descriptive data of patients with goiter and controls.
Patient (n = 52) Control (n = 31)
Age (mean ± SD) 47.37 ±12.22 39.29 ±13.32
Gender
Males 6 (11.5%) 17 (54.8%)
Females 46 (88.5%) 14 (45.2%)
Smoking
No 33 (63.5%) 20 (64.5%)
Yes 19 (36.5%) 11 (35.5%)
Allergy
Absent 46 (88.5%) 28 (90.3%)
Present 6 (11.5%) 3 (9.7%)
Duration of disease in years (mean ± SD) 3.32 ±4.17 N/A
Nodules N/A
Absent 10 (19.2%)
Present 42 (80.8%)
∗TSH N/A
Hyperthyroid 5 (9.6%)
Euthyroid 36 (69.2%)
Hypothyroid 5 (9.6%)
Missing 6 (11.5%)
∗TSH: hyper-thyroid (<0.27); euthyroid (0.27–4.20); hypothyroid (>4.20).
Table 2: Reﬂux among patients and controls.
∗Reﬂux Patient Control P value
No 44 (84.6%) 28 (90.3%) 0.525
Yes 8 (15.4%) 3 (9.7%)
∗RSI: No ≤ 10; Yes > 10.
patients with throat or vocal complaints have been shown
to have LPRD [8]. The diagnosis is invariably made through
a detailed history taking and a laryngeal examination. The
presence of many laryngopharyngeal symptoms, such as
change in voice quality, throat clearing, globus, and dys-
phagia, leads to the diagnosis of LPRD. This later is further
conﬁrmed by the laryngeal ﬁndings of edema, thick mucus,
obliteration of the sinus of Morgagni, and the medialization
of the false cords among others. The compilation of these
ﬁndings and complaints under the Reﬂux Finding score and
Reﬂux Symptom Index by Belafsky are commonly used diag-
nostictoolsthathavebeenvalidatedincomparisontodouble
probe pH-metry. Other diagnostic tests include detection of
pepsin in the sputum, laryngeal sensory testing, Laryn-
gopharyngeal sensory discrimination testing (FEESST), eso-
phagoscopy, barium esophagography, and Bernstein acid
perfusion [9]. The authors of this paper have elected to use
the RSI questionnaire as a diagnostic test for the presence of
LPRD in patients with goiter and controls.
Patients with goiter often complain of neck symptoms
and disﬁgurement related to their neck mass. Local symp-
toms in patients with euthyroid goiter undergoing surgery
have been reported to vary between 13 to 50% [14, 15].
Among these are swallowing disorders, voice disturbances,
and throat discomfort. These complaints have been linked to
the presence of nodules in thyroid diseases and total thy-
roidectomy has been oﬀered as a treatment option for these
patients [15, 16]. The persistence of these neck symptoms
following surgery has been linked to the side eﬀects of endo-
tracheal intubation, injury to the perivascular neural plexus
innervating the pharyngeal and laryngeal structures, and the
normal healing process that is presumed to hinder or im-
pair the vertical movement of the laryngotracheal complex
[17, 18].
Recently, Fiorentino et al. [10] suggested that goiter
patients may be at risk of undertreatment of LPRD and that
many of these symptoms are LPRD symptoms that overlap
with those commonly found in cases of goiter. As such the
diagnosis of LPRD may be overlooked as all local neck symp-
toms are attributed to the goiter. Especially in patients whose
goiters are only being monitored, and not removed, such
symptoms may continue to be endured without any further
thought to their etiology. This has been proven by the per-
sistence of swallowing and voice disorders and throat dis-
comfort even three months after surgery. Based on Fioren-
tino’s investigation, these symptoms have been associated
with laryngopharyngitis as evidenced by videolaryngoscopy
and videoﬂuoroscopic swallowing studies. The results of
Fiorentino were in accordance with previous studies by Per-
eira et al. reporting the persistence of local neck symptoms
in 48% of patients undergoing surgery and the emergence of
thesesymptomssubsequenttothyroidectomiesin45%ofthe
cases [14].
The results of our study indicate that almost 15.4% of
patients with goiter had LPRD. Even though the diﬀerence
in prevalence was not signiﬁcant compared to controls, the
average scoring grade of all LPRD symptoms was greater in4 ISRN Endocrinology
Table 3: Reﬂux symptom index among patients and controls.
Patients Controls P value
mean ± SD mean ± SD
Hoarseness or a problem voice 0.87 ±1.28 0.55 ±0.85 0.346
Clearing of throat 1.08 ±1.27 0.77 ±0.99 0.314
Excess throat mucus or postnasal drip 0.71 ±1.29 0.42 ±0.85 0.550
Diﬃculty swallowing food, liquids, or pills 0.54 ±1.02 0.26 ±0.73 0.114
Coughing after you ate or lie down 0.44 ±0.67 0.35 ±0.66 0.522
Breathing diﬃculties or choking episodes 0.31 ±0.67 0.13 ±0.43 0.227
Troublesome or annoying cough 0.33 ±0.83 0.16 ±0.45 0.532
Sensations of something sticking throat or a lump in throat 0.73 ±1.07 0.52 ±0.93 0.280
Heartburn, chest pain, indigestion, or stomach acid coming up 1.35 ±1.28 1.06 ±1.37 0.255
Table 4: Possible correlations with the total reﬂux index (RSI).
Total reﬂux (RSI) P value
Absent (≤10) Present (>10)
Age (mean ± SD) 47.11 ±12.21 48.75 ±13.04 0.731
Duration of disease (mean ± SD) 3.29 ±4.47 3.50 ±2.00 0.162
Gender 0.227
Male 4 (66.7%) 2 (33.3%)
Female 40 (87.0%) 6 (13.0%)
Nodules 0.035∗
Absent 6 (60.0%) 4 (40.0%)
Present 38 (90.5%) 4 (9.5%)
TSH 0.103
Hyperthyroid 3 (60.0%) 2 (40.0%)
Euthyroid 32 (88.9%) 4 (11.1%)
Hypothyroid 3 (60.0%) 2 (40.0%)
∗Signiﬁcant results (P<0.05).
patients with goiter. Several mechanisms can be responsible
for the higher prevalence of LPRD and the higher scoring
of the above-mentioned symptoms in patients with goiter
compared to controls. One is the possible dysfunction of
the upper esophageal sphincter (UES) as lower esophageal
sphincter pressure in goitrous patients has been previously
reported [19]. The UES dysfunction could be attributed to
the mass eﬀect of the hypertrophic gland on the cricopha-
ryngeal and constrictor muscles or to vagal neuropathy. The
UES is primarily innervated by the recurrent laryngeal nerve
(RLN) which can be aﬀected in patients with goiter. In his
study on three specimens of the UES obtained from human
autopsies examined by Shiler’s stain, Mu and Sanders found
thatthecricopharyngeal(CP)musclereceivesitsinnervation
frombelowviatherecurrentlaryngealnerve(RLN)andfrom
above via the pharyngeal plexus and the upper esophagus
(UE) is innervated by the RLN [20]. Evidence for RLN dys-
function in patients with benign thyroid lesions exists [21].
Indeed, case reports of both unilateral and bilateral RLN
paralysis in patients with benign multinodular goiter have
been presented, especially in cases of substernal goiter [22,
23]. The prevalence varies between diﬀerent studies. Holl-
Allen has reported an incidence of 0.69% in 1156 patients
withbenignthyroiddisease,fortypercentofwhichrecovered
after surgery [24]. His results were further commemorated
by many authors reporting similar incidences [25–27]. The
basic mechanism behind the paralysis or paresis is perineural
inﬂammation and ﬁbrosis, stretching of the recurrent laryn-
geal nerve by the hypertrophic gland, compression, and or
thrombosis of the vasa nervosa.
Another explanation for the high prevalence of LPRD
in patients with goiter is the delayed esophageal peristalsis
reported in these patients by Pustorino [19]. Such peristalsis
dysfunctioncanbefurtherexacerbatedifthegoiterisaccom-
panied by hypo- or hyperthyroidism [28]. Several studies
have reported gastrointestinal motility dysfunction in associ-
ation with hypo- and hyperthyroidism. Patients with hypo-
thyroidism have been shown to have delayed gastric emp-
tying and disturbed esophageal mobility. A recent study by
Yaylali et al. using esophageal scintigraphy on thirty females
subjects with hypothyroidism revealed a marked increase in
the mean esophageal transit time and gastric emptying, with
no correlation between the level of hypothyroidism and ab-
normalities in gastrointestinal system kinetics [29, 30]. The
possible mechanism for these ﬁndings is the accumulation of
mucinous material (mucopolysaccharides) in the gastroin-
testinal system mucosa, leading to dysmotility [31, 32]. This
possibilityisunlikelyinourstudyinviewofthefactthat70%
of patients with goiter had TSH within normal range.
The limitation of this study is the lack of laryngeal exam-
ination to assess the laryngeal ﬁndings secondary to LPRD,
and to record the vocal fold mobility in patients with goiter.ISRN Endocrinology 5
Nevertheless it is the ﬁrst study to highlight the prevalence of
LPRD in a nonbiased group of patients with goiter.
5. Conclusion
Because of the overlap between LPRD symptoms and neck
complaints of patients with goiter, it is important to know
the prevalence of LPRD in this group of patients. The results
of our study indicate a higher prevalence of all laryngo-
pharyngeal reﬂux disease symptoms in patients with goiter
and correlation between LPRD and nodular goiter. As such,
goiterous patients need to be treated for LPRD when present,
before being scheduled for surgery with the assumption that
their neck throat, voice, and swallowing symptoms are sec-
ondary to their goiter.
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